Special Heart Disease

Special Heart Disease

Thesis Statement

A meta-analysis of interventional trials showed that cholesterol-lowering therapy was associated with high mortality in a population with low cardiovascular risk (heart disease).

Introduction

Both medical professionals and patients are well aware of the dangers of high cholesterol, but most know little about the risks of low cholesterol, despite the many studies that have examined the issue to determine the root cause of special heart disease. However, there is no explicit evidence that these relationships are causal (Bernard and Gersh, p.124).

To clarify this issue, it was investigated that the relationship between cholesterol and mortality with respect to cause of death (due to heart disease) (Alvin and Laura, p. 25).

Every year approximately 17 million people worldwide die of cardiovascular disease (heart disease), which accounts for around 4 million deaths in Europe and 650,000 deaths in the US. Specifically, acute myocardial infarction (MI) is the leading cause of death in the US and Europe. In 2006 around 24 .1 million people were living with heart disease in the US alone. In addition to mortality heart disease is also associated with high rates of morbidity (Barry and Maron, p.119).

Discussion

According to the statistics of the World Health Organization (WHO) estimates that, in the US, a person with heart disease loses 10-19 years of healthy life. It is not surprising that since 1900, heart disease has been the leading cause of death in the US every year except 1918. Heart disease is not unique to the US; heart disease death rates are particularly high in Eastern European countries such as Russia, whereas the lowest heart disease death rates are in Japan and France (Alvin and Laura, p. 28). Although many different causes contribute to varied heart disease death rates in different countries, these death rates do not appear ...